| __timestamp | Evotec SE | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17990000 | 504755000 |
| Thursday, January 1, 2015 | 25166000 | 838526000 |
| Friday, January 1, 2016 | 27013000 | 1177697000 |
| Sunday, January 1, 2017 | 42383000 | 1320433000 |
| Monday, January 1, 2018 | 57012000 | 1556200000 |
| Tuesday, January 1, 2019 | 66546000 | 1834800000 |
| Wednesday, January 1, 2020 | 77238000 | 1346000000 |
| Friday, January 1, 2021 | 105445000 | 1824900000 |
| Saturday, January 1, 2022 | 156190000 | 2115900000 |
| Sunday, January 1, 2023 | 169610000 | 2631300000 |
| Monday, January 1, 2024 | 2954400000 |
Cracking the code
In the competitive world of biotechnology, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Regeneron Pharmaceuticals, Inc. and Evotec SE from 2014 to 2023. Regeneron, a leader in the industry, consistently outpaces Evotec in SG&A spending, reflecting its larger scale and broader market reach. In 2023, Regeneron's SG&A expenses were approximately 15 times higher than Evotec's, highlighting its significant investment in administrative and sales functions. Over the decade, Regeneron's expenses grew by over 400%, while Evotec's increased by nearly 900%, indicating rapid expansion. This data provides a fascinating insight into how these companies allocate resources to maintain their competitive edge. As the biotech landscape evolves, monitoring these trends offers valuable lessons in strategic financial management.
Selling, General, and Administrative Costs: Johnson & Johnson vs Regeneron Pharmaceuticals, Inc.
Comparing SG&A Expenses: Johnson & Johnson vs Evotec SE Trends and Insights
Breaking Down SG&A Expenses: Sanofi vs Regeneron Pharmaceuticals, Inc.
Comparing SG&A Expenses: Bristol-Myers Squibb Company vs Regeneron Pharmaceuticals, Inc. Trends and Insights
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Insmed Incorporated
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Evotec SE
Cost Management Insights: SG&A Expenses for Regeneron Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Evotec SE
Wave Life Sciences Ltd. vs Evotec SE: SG&A Expense Trends
Evotec SE and Xencor, Inc.: SG&A Spending Patterns Compared
Evotec SE and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared